Key result
Wearable equipment-based telemedical management reduced hospitalisation (HR 0.59; 95% CI 0.47-0.73; p<0.0001) and major adverse cardiac events compared with traditional follow-up.
Why the study?
Chronic coronary heart disease prevalence increases with age in the elderly and represents a major cause of death and disease burden, prompting evaluation of remote multiparameter telemedical management.
Does wearable equipment-based telemedical management reduce hospitalisation and major adverse cardiac events in elderly patients with chronic coronary heart disease?
RCT (n=1,248)
Open-label
randomly divided
Does wearable equipment-based telemedical management reduce hospitalisation and major adverse cardiac events in elderly patients with chronic coronary heart disease?
Hazard Ratio: 0.59 (95% CI 0.47–0.73)
p-value: p=<0.0001
Wearable equipment-based telemedical management significantly reduces hospitalizations and major adverse cardiac events in elderly patients with chronic coronary heart disease compared to traditional follow-up.
Reduces MACE and hospitalizations in elderly CHD; extends RCT evidence for wearable multiparameter telemonitoring.
BACKGROUND: The prevalence of chronic coronary heart diseases (CHDs) increases with age in the elderly, which represents one of the top-ranked causes of death and disease burden. METHODS: This study aimed to investigate the management efficiency of telemedicine based on the remote multiparameter monitoring in elderly patients with CHD. A total of 1248 elderly patients diagnosed with CHD were enrolled. The subjects were randomly divided into two groups, wearable equipment-based telemedical management (WTM) group and traditional follow-up management (TFM) group. Face-to-face clinical interview at least once every 2 months was required in TFM group to collect the medical records. Patients in WTM group were provided with wearable equipment to complete remote monitoring, real-time alerts and health intervention via virtual consultations and remote medication recommendations. RESULTS: The mean age of patients in WTM group and TFM group was 71.1 (68.0-82.0) years and 71.0 (68.0-81.0) years, respectively. After a 12-month management, patients in WTM group presented a lower occurrence of hospitalisation (HR 0.59, 95% CI=0.47 to 0.73, p<0.0001) and major adverse cardiac events (HR 0.60, 95% CI=0.44 to 0.82, p=0.0012) compared with patients in TFM group. CONCLUSION: The multiparameter telemedical management could help with the out-of-hospital management and reduce the incidence of rehospitalisation in elderly patients with CHD.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2024) conducted an RCT in chronic coronary heart disease (n=1,248). Wearable equipment-based telemedical management vs. Traditional follow-up management was evaluated on hospitalisation (HR 0.59, 95% CI 0.47 to 0.73, p=<0.0001). Wearable equipment-based telemedical management reduced hospitalisation (HR 0.59; 95% CI 0.47-0.73; p<0.0001) and major adverse cardiac events compared with traditional follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: